Cell Biology and Toxicology

, Volume 26, Issue 6, pp 499–507 | Cite as

A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines

  • Xiaolan HuEmail author
  • Shuxin Lin
  • Daihua Yu
  • Shuifeng Qiu
  • Xianqi Zhang
  • Ruhuan Mei


Salidroside (p-hydroxyphenethyl-beta-d-glucoside), which is present in all species of the genus Rhodiola, has been reported to have a broad spectrum of pharmacological properties. The present study, for the first time, focused on evaluating the effects of the purified salidroside on the proliferation of various human cancer cell lines derived from different tissues, and further investigating its possible molecular mechanisms. Cell viability assay and [3H] thymidine incorporation were used to evaluate the cytotoxic effects of salidroside on cancer cell lines, and flow cytometry analyzed the change of cell cycle distribution induced by salidroside. Western immunoblotting further studied the expression changes of cyclins (cyclin D1 and cyclin B1), cyclin-dependent kinases (CDK4 and Cdc2), and cyclin-dependent kinase inhibitors (p21Cip1 and p27Kip1). The results showed that salidroside inhibited the growth of various human cancer cell lines in concentration- and time-dependent manners, and the sensitivity to salidroside was different in those cancer cell lines. Salidroside could cause G1-phase or G2-phase arrest in different cancer cell lines, meanwhile, salidroside resulted in a decrease of CDK4, cyclin D1, cyclin B1 and Cdc2, and upregulated the levels of p27Kip1 and p21Cip1. Taken together, salidroside could inhibit the growth of cancer cells by modulating CDK4-cyclin D1 pathway for G1-phase arrest and/or modulating the Cdc2-cyclin B1 pathway for G2-phase arrest.


Salidroside Cancer cells Cell proliferation Cell cycle arrest 



American Tissue Culture Collection


Cyclin-dependent kinase


Cyclin-dependent kinase inhibitor


Cyclin-dependent kinase 4


Cell division cycle protein 2


Cdk-interacting protein1


Kinase inhibitor protein


3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide


Propidium iodide



This study was partly supported by a grant from Medicine Health Science Research Fund of PLA (No: 01L003) and was supported in part by a grant awarded to Zhejiang Provincial Natural Science Foundation (Y2080271).


  1. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008;14:159–69.CrossRefPubMedGoogle Scholar
  2. Chen X, Liu J, Gu X, Ding F. Salidroside attenuates glutamate-induced apoptotic cell death in primary cultured hippocampal neurons of rats. Brain Res. 2008;1238:189–98.CrossRefPubMedGoogle Scholar
  3. Coqueret O. Linking cyclins to transcriptional control. Gene. 2002;299:35–55.CrossRefPubMedGoogle Scholar
  4. Foijer F, Delzenne-Goette E, Dekker M, Te Riele H. In vivo significance of the G2 restriction point. Cancer Res. 2007;67:9244–7.CrossRefPubMedGoogle Scholar
  5. Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38:1249–53.CrossRefPubMedGoogle Scholar
  6. Goel HC, Bala M, Prasad J, Singh S, Agrawala PK, Swahney RC. Radioprotection by Rhodiola imbricata in mice against whole-body lethal irradiation. J Med Food. 2006;9:154–60.CrossRefPubMedGoogle Scholar
  7. Ihenetu K, Qazzaz HM, Crespo F, Fernandez-Botran R, Valdes Jr R. Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia. Clin Chem. 2007;53:1315–22.CrossRefPubMedGoogle Scholar
  8. Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res. 2006;20:424–5.CrossRefPubMedGoogle Scholar
  9. Li W, Sanki A, Karim RZ, Thompson JF, Soon Lee C, Zhuang L, et al. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology. 2006;38:287–301.CrossRefPubMedGoogle Scholar
  10. Marchetti S, Mazzanti R, Beijnen JH, Schellens JH. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist. 2007;12:927–41.CrossRefPubMedGoogle Scholar
  11. Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, et al. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res. 2005;19:740–3.CrossRefPubMedGoogle Scholar
  12. Mishra KP, Padwad YS, Dutta A, Ganju L, Sairam M, Banerjee PK, et al. Aqueous extract of Rhodiola imbricata rhizome inhibits proliferation of an erythroleukemic cell line K-562 by inducing apoptosis and cell cycle arrest at G2/M phase. Immunobiology. 2008;213:125–31.CrossRefPubMedGoogle Scholar
  13. Nagini S. Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise? Anticancer Agents Med Chem. 2008;8:313–21.CrossRefPubMedGoogle Scholar
  14. Perfumi M, Mattioli L. Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res. 2007;21:37–43.CrossRefPubMedGoogle Scholar
  15. Pooja D, Bawa AS, Khanum F. Anti-inflammatory activity of Rhodiola rosea–"a second-generation adaptogen". Phytother Res. 2009;23:1099–102.CrossRefGoogle Scholar
  16. Schriner SE, Abrahamyan A, Avanessian A, Bussel I, Maler S, Gazarian M, et al. Decreased mitochondrial superoxide levels and enhanced protection against paraquat in Drosophila melanogaster supplemented with Rhodiola rosea. Free Radic Res. 2009;43:836–43.CrossRefPubMedGoogle Scholar
  17. Skopińska-Rózewska E, Malinowski M, Wasiutyński A, Sommer E, Furmanowa M, Mazurkiewicz M, et al. The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol J Vet Sci. 2008;11:97–104.PubMedGoogle Scholar
  18. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. Double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. 2000;7:85–9.PubMedGoogle Scholar
  19. Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, et al. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Mol Cancer Ther. 2008;7:10–8.CrossRefPubMedGoogle Scholar
  20. Takagaki N, Sowa Y, Oki T, Nakanishi R, Yogosawa S, Sakai T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int J Oncol. 2005;26:185–9.PubMedGoogle Scholar
  21. Udintsev SN, Shakhov VP. The role of humoral factors of regenerating liver in the development of experimental tumors and the effect of Rhodiola rosea extract on this process. Neoplasma. 1991;38:323–31.PubMedGoogle Scholar
  22. Vickers AJ. Which botanicals or other unconventional anticancer agents should we take to clinical trial? J Soc Integr Oncol. 2007;5:125–9.CrossRefPubMedGoogle Scholar
  23. Wang H, Ding Y, Zhou J, Sun X, Wang S. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine. 2009;16:146–55.CrossRefPubMedGoogle Scholar
  24. Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, et al. Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev. 2009;18:331–41.CrossRefPubMedGoogle Scholar
  25. Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005;65:1035–44.CrossRefPubMedGoogle Scholar
  26. Zhang L, Yu H, Sun Y, Lin X, Chen B, Tan C, et al. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol. 2007;564:18–25.CrossRefPubMedGoogle Scholar
  27. Zhang J, Liu A, Hou R, Zhang J, Jia X, Jiang W, et al. Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. Eur J Pharmacol. 2009;607:6–14.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Xiaolan Hu
    • 1
    Email author
  • Shuxin Lin
    • 2
  • Daihua Yu
    • 2
  • Shuifeng Qiu
    • 1
  • Xianqi Zhang
    • 1
  • Ruhuan Mei
    • 1
  1. 1.Department of Pathology and PathophysiologyZhejiang University School of MedicineHangzhouChina
  2. 2.Department of PathophysiologyFourth Military Medical UniversityXi’anChina

Personalised recommendations